PRAMOXINE HYDROCHLORIDE, MENTHOL

PRAMOXINE HYDROCHLORIDE, MENTHOL was reported 212 times

PRAMOXINE HYDROCHLORIDE, MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SALIVARY GLAND OPERATION 1 0.0312
1 ENOSTOSIS 1 0.0179
2 NEPHROGENIC FIBROSING DERMOPATHY 3 0.0150
3 SCOLIOSIS SURGERY 1 0.0139
4 MYELOBLAST COUNT INCREASED 1 0.0130
5 PHARYNGO-OESOPHAGEAL DIVERTICULUM 1 0.0110
6 URETERIC INJURY 1 0.0089
7 REPETITIVE STRAIN INJURY 1 0.0088
8 CHOROID MELANOMA 1 0.0088
9 CYSTOPEXY 1 0.0085
10 PARANASAL SINUS MUCOSAL HYPERTROPHY 1 0.0084
11 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
12 SUPERIOR VENA CAVAL OCCLUSION 1 0.0079
13 MEDICAL DEVICE SITE ERYTHEMA 1 0.0078
14 TONSILLOLITH 1 0.0071
15 DISSEMINATED COCCIDIOIDOMYCOSIS 1 0.0071
16 TRACHEAL INJURY 1 0.0068
17 CARDIOLIPIN ANTIBODY POSITIVE 1 0.0055
18 ATONIC URINARY BLADDER 1 0.0052
19 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
20 BENIGN HEPATIC NEOPLASM 1 0.0050
21 SALMONELLA BACTERAEMIA 1 0.0048
22 CONJUNCTIVITIS VIRAL 1 0.0038
23 ANDROGENETIC ALOPECIA 1 0.0035
24 IMPLANT SITE EROSION 1 0.0034
25 CATHETER SITE HAEMATOMA 1 0.0034
26 BIOPSY BREAST 1 0.0032
27 JOINT ABSCESS 1 0.0029
28 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
29 VAGINAL FISTULA 1 0.0028
30 NASAL TURBINATE HYPERTROPHY 1 0.0027
31 PERIPROSTHETIC FRACTURE 1 0.0026
32 ALBUMIN URINE PRESENT 1 0.0026
33 RADIATION OESOPHAGITIS 1 0.0026
34 VIRAL RASH 1 0.0025
35 PHLEBITIS SUPERFICIAL 1 0.0024
36 URINARY TRACT INFECTION STAPHYLOCOCCAL 1 0.0023
37 PSEUDOMONAL BACTERAEMIA 2 0.0023
38 OESOPHAGEAL INFECTION 1 0.0022
39 SKIN FIBROSIS 1 0.0021
40 ECZEMA NUMMULAR 1 0.0020
41 APPLICATION SITE INFECTION 1 0.0020
42 POLYOMAVIRUS VIRAEMIA 2 0.0019
43 INADEQUATE DIET 1 0.0019
44 MEDICAL DEVICE SITE PAIN 1 0.0018
45 INTERNAL FIXATION OF FRACTURE 1 0.0018
46 URINARY TRACT INFECTION FUNGAL 1 0.0017
47 OPHTHALMIC HERPES SIMPLEX 1 0.0017
48 EJECTION FRACTION 1 0.0017
49 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
50 SICKLE CELL ANAEMIA 1 0.0016
51 SPUTUM ABNORMAL 1 0.0015
52 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
53 MONOCYTE PERCENTAGE INCREASED 1 0.0014
54 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
55 CALCULUS URETERIC 1 0.0014
56 BACTERIAL DISEASE CARRIER 1 0.0014
57 FIBROCYSTIC BREAST DISEASE 1 0.0014
58 WOUND DRAINAGE 1 0.0013
59 HAPTOGLOBIN DECREASED 1 0.0012
60 ADRENAL MASS 1 0.0012
61 FUNGAL SEPSIS 1 0.0012
62 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
63 BLOOD PROLACTIN ABNORMAL 1 0.0012
64 GASTROINTESTINAL FISTULA 1 0.0011
65 BLOOD ALBUMIN INCREASED 1 0.0011
66 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
67 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
68 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
69 BONE GRAFT 1 0.0011
70 VASCULAR PAIN 1 0.0010
71 EPIDERMAL NECROSIS 1 0.0010
72 OEDEMA MUCOSAL 1 0.0010
73 CARPAL TUNNEL DECOMPRESSION 1 0.0009
74 ENTEROCOCCAL BACTERAEMIA 1 0.0009
75 HAEMOGLOBINURIA 1 0.0009
76 T-CELL LYMPHOMA 1 0.0009
77 PELVIC ABSCESS 1 0.0009
78 APPLICATION SITE DISCHARGE 1 0.0009
79 ESCHERICHIA BACTERAEMIA 2 0.0008
80 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 1 0.0008
81 CHRONIC RESPIRATORY FAILURE 1 0.0008
82 MONOCYTE COUNT DECREASED 1 0.0008
83 BLADDER PROLAPSE 1 0.0008
84 STEM CELL TRANSPLANT 2 0.0008
85 NASAL PRURITUS 1 0.0008
86 BRONCHIAL SECRETION RETENTION 1 0.0008
87 CALCIUM DEFICIENCY 1 0.0008
88 ANAEMIA POSTOPERATIVE 1 0.0008
89 CARBON DIOXIDE INCREASED 1 0.0007
90 FRACTURE NONUNION 1 0.0007
91 BRONCHIAL OBSTRUCTION 1 0.0007
92 PELVIC VENOUS THROMBOSIS 1 0.0007
93 INVESTIGATION ABNORMAL 1 0.0007
94 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
95 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
96 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
97 CALCULUS URINARY 1 0.0006
98 COAGULATION TIME PROLONGED 1 0.0006
99 OVARIAN CANCER RECURRENT 1 0.0006
100 RENAL CELL CARCINOMA 3 0.0006
101 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
102 ENTEROBACTER INFECTION 1 0.0006
103 SALMONELLOSIS 1 0.0006
104 BLOOD CHLORIDE INCREASED 1 0.0006
105 MEDICAL DEVICE REMOVAL 1 0.0006
106 JUGULAR VEIN THROMBOSIS 1 0.0006
107 PNEUMOMEDIASTINUM 1 0.0006
108 BODY TEMPERATURE ABNORMAL 1 0.0005
109 DIFFUSE ALOPECIA 1 0.0005
110 BLADDER SPASM 1 0.0005
111 PROTEIN TOTAL DECREASED 2 0.0005
112 HYPERCOAGULATION 1 0.0005
113 OCCULT BLOOD POSITIVE 1 0.0005
114 PNEUMONIA FUNGAL 2 0.0005
115 POLYDIPSIA 2 0.0005
116 HYPERPHAGIA 2 0.0005
117 HYPOPHYSITIS 1 0.0005
118 DEVICE RELATED SEPSIS 1 0.0005
119 DERMATITIS PSORIASIFORM 1 0.0005
120 INTRAMEDULLARY ROD INSERTION 1 0.0005
121 SKIN INDURATION 1 0.0005
122 ATRIAL TACHYCARDIA 1 0.0005
123 NEUROGENIC BLADDER 1 0.0005
124 LICHENOID KERATOSIS 1 0.0004
125 BILIRUBIN CONJUGATED INCREASED 1 0.0004
126 VITILIGO 1 0.0004
127 RETINAL TEAR 1 0.0004
128 VEIN DISORDER 2 0.0004
129 HYPERPARATHYROIDISM SECONDARY 1 0.0004
130 URINARY TRACT INFECTION BACTERIAL 1 0.0004
131 SEDATION COMPLICATION 1 0.0004
132 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
133 HERNIA REPAIR 1 0.0004
134 BLOOD ALBUMIN DECREASED 3 0.0004
135 PROTEIN TOTAL INCREASED 1 0.0004
136 MIGRAINE WITH AURA 1 0.0004
137 RED BLOOD CELL COUNT INCREASED 1 0.0004
138 RASH MORBILLIFORM 1 0.0004
139 CHOLECYSTITIS INFECTIVE 1 0.0004
140 DRUG TOLERANCE DECREASED 1 0.0004
141 SKIN HYPERTROPHY 1 0.0004
142 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
143 EYELID MARGIN CRUSTING 1 0.0003
144 ADENOVIRUS INFECTION 1 0.0003
145 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
146 VARICES OESOPHAGEAL 1 0.0003
147 EMBOLISM VENOUS 1 0.0003
148 FIBROSIS 1 0.0003
149 DIASTOLIC DYSFUNCTION 1 0.0003
150 PNEUMONIA VIRAL 1 0.0003
151 FACET JOINT SYNDROME 1 0.0003
152 DEAFNESS NEUROSENSORY 1 0.0003
153 NEAR DEATH EXPERIENCE 1 0.0003
154 CERVICAL VERTEBRAL FRACTURE 1 0.0003
155 AORTIC STENOSIS 1 0.0003
156 LOGORRHOEA 1 0.0003
157 NECROTISING FASCIITIS 1 0.0003
158 GRAFT VERSUS HOST DISEASE 2 0.0003
159 MONOCYTE COUNT INCREASED 1 0.0003
160 HYPOPHOSPHATAEMIA 2 0.0003
161 PARANASAL SINUS DISCOMFORT 1 0.0003
162 OESOPHAGEAL DISORDER 1 0.0003
163 HAEMOLYSIS 2 0.0003
164 SENSATION OF HEAVINESS 1 0.0003
165 BACTERAEMIA 3 0.0003
166 OESOPHAGEAL CANDIDIASIS 1 0.0003
167 BLEPHARITIS 1 0.0002
168 ENURESIS 1 0.0002
169 APPLICATION SITE DISCOLOURATION 1 0.0002
170 APPLICATION SITE EXFOLIATION 1 0.0002
171 EMBOLISM 2 0.0002
172 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
173 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
174 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
175 ABSCESS LIMB 1 0.0002
176 PURULENT DISCHARGE 1 0.0002
177 SHOULDER OPERATION 1 0.0002
178 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
179 PULMONARY FUNCTION TEST DECREASED 1 0.0002
180 GROIN PAIN 2 0.0002
181 BLOOD CREATINE INCREASED 1 0.0002
182 HAEMOGLOBIN INCREASED 1 0.0002
183 NEPHROGENIC ANAEMIA 1 0.0002
184 HYPOMAGNESAEMIA 3 0.0002
185 PERFORMANCE STATUS DECREASED 1 0.0002
186 SKIN TIGHTNESS 1 0.0002
187 SKIN ABRASION 1 0.0002
188 FAECAL INCONTINENCE 1 0.0002
189 HYPERCHOLESTEROLAEMIA 2 0.0002
190 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
191 STAPHYLOCOCCAL SEPSIS 1 0.0002
192 DIABETIC NEUROPATHY 1 0.0002
193 ORGANISING PNEUMONIA 1 0.0002
194 IMMUNODEFICIENCY 3 0.0002
195 HYPERNATRAEMIA 1 0.0002
196 APPLICATION SITE SWELLING 1 0.0002
197 INITIAL INSOMNIA 2 0.0002
198 EYE DISCHARGE 2 0.0002
199 SCRATCH 2 0.0002
200 SERUM FERRITIN INCREASED 1 0.0002
201 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
202 GINGIVITIS 1 0.0002
203 BLOOD BILIRUBIN INCREASED 5 0.0002
204 HYPERKERATOSIS 1 0.0002
205 MALNUTRITION 2 0.0002
206 SKIN INFECTION 2 0.0002
207 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
208 HYPERTONIA 1 0.0002
209 SKIN ATROPHY 1 0.0002
210 ENTEROCOLITIS 1 0.0002
211 HYPERVENTILATION 1 0.0002
212 HYPOVOLAEMIA 1 0.0002
213 HYPERTRIGLYCERIDAEMIA 1 0.0002
214 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
215 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
216 PLEURISY 1 0.0002
217 ODYNOPHAGIA 1 0.0002
218 HEARING IMPAIRED 1 0.0002
219 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
220 VULVOVAGINAL BURNING SENSATION 1 0.0002
221 SCOLIOSIS 1 0.0002
222 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
223 THERAPEUTIC RESPONSE CHANGED 1 0.0002
224 LOWER LIMB FRACTURE 3 0.0002
225 CARDIAC FLUTTER 1 0.0002
226 ASPERGILLUS INFECTION 1 0.0002
227 HAEMATOCRIT DECREASED 3 0.0002
228 UPPER LIMB FRACTURE 3 0.0002
229 POST-TRAUMATIC STRESS DISORDER 1 0.0001
230 BRONCHIECTASIS 1 0.0001
231 ULCER HAEMORRHAGE 1 0.0001
232 JOINT EFFUSION 1 0.0001
233 LYMPHOEDEMA 1 0.0001
234 LARGE INTESTINE POLYP 1 0.0001
235 HYPERTRANSAMINASAEMIA 1 0.0001
236 DIALYSIS 2 0.0001
237 SINUS TACHYCARDIA 2 0.0001
238 RED BLOOD CELL COUNT DECREASED 4 0.0001
239 DERMATITIS BULLOUS 1 0.0001
240 FAECES SOFT 1 0.0001
241 RASH PUSTULAR 1 0.0001
242 ORAL DISORDER 1 0.0001
243 BLINDNESS TRANSIENT 1 0.0001
244 STEVENS-JOHNSON SYNDROME 3 0.0001
245 HAEMODYNAMIC INSTABILITY 1 0.0001
246 FOOD ALLERGY 1 0.0001
247 APHTHOUS ULCER 1 0.0001
248 HAEMORRHAGIC STROKE 1 0.0001
249 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
250 AFFECTIVE DISORDER 1 0.0001
251 HAEMOGLOBIN DECREASED 13 0.0001
252 FURUNCLE 1 0.0001
253 HYPOTHYROIDISM 4 0.0001
254 DECUBITUS ULCER 1 0.0001
255 METASTASES TO BONE 2 0.0001
256 ESCHERICHIA INFECTION 1 0.0001
257 CYTOMEGALOVIRUS INFECTION 2 0.0001
258 EOSINOPHIL COUNT INCREASED 1 0.0001
259 HAEMODIALYSIS 1 0.0001
260 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
261 PSYCHOLOGICAL TRAUMA 1 0.0001
262 MUSCLE STRAIN 1 0.0001
263 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
264 APPLICATION SITE ERYTHEMA 3 0.0001
265 RASH MACULAR 4 0.0001
266 PRODUCT COMMUNICATION ISSUE 1 0.0001
267 LYMPHOCYTE COUNT DECREASED 2 0.0001
268 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
269 RESPIRATORY RATE INCREASED 1 0.0001
270 HAEMOLYTIC ANAEMIA 1 0.0001
271 UROSEPSIS 1 0.0001
272 NERVE COMPRESSION 1 0.0001
273 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
274 DEEP VEIN THROMBOSIS 7 0.0001
275 PANCYTOPENIA 6 0.0001
276 NEPHROPATHY 1 0.0001
277 FLANK PAIN 1 0.0001
278 SQUAMOUS CELL CARCINOMA 1 0.0001
279 ACUTE RESPIRATORY FAILURE 2 0.0001
280 VITAMIN D DEFICIENCY 1 0.0001
281 BODY TEMPERATURE DECREASED 1 0.0001
282 NEUTROPHIL COUNT INCREASED 1 0.0001
283 EUPHORIC MOOD 1 0.0001
284 VENTRICULAR EXTRASYSTOLES 1 0.0001
285 WEIGHT FLUCTUATION 1 0.0001
286 CYSTITIS 3 0.0001
287 POOR QUALITY SLEEP 2 0.0001
288 RASH PRURITIC 5 0.0001
289 FAECES DISCOLOURED 2 0.0001
290 SKIN LACERATION 1 0.0001
291 PULMONARY THROMBOSIS 1 0.0001
292 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
293 WOUND INFECTION 1 0.0001
294 PRURITUS 35 0.0001
295 RASH PAPULAR 2 0.0001
296 OCULAR DISCOMFORT 1 0.0001
297 BLOOD CALCIUM DECREASED 1 0.0001
298 APPLICATION SITE PRURITUS 2 0.0001
299 GASTRIC HAEMORRHAGE 1 0.0001
300 COVID-19 PNEUMONIA 1 0.0001
301 BLOOD IRON DECREASED 1 0.0001
302 RASH ERYTHEMATOUS 4 0.0001
303 ADRENAL INSUFFICIENCY 1 0.0001
304 HYPERGLYCAEMIA 3 0.0001
305 SPINAL OPERATION 1 0.0001
306 ABASIA 2 0.0001
307 CYST 1 0.0001
308 APPLICATION SITE IRRITATION 1 0.0001
309 PNEUMONIA ASPIRATION 2 0.0001
310 HYPOPHAGIA 2 0.0001
311 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
312 INFUSION SITE PAIN 1 0.0001
313 EXPOSURE VIA SKIN CONTACT 2 0.0001
314 ANHEDONIA 2 0.0001
315 SARS-COV-2 TEST POSITIVE 1 0.0001
316 TACHYPNOEA 1 0.0001
317 MENTAL STATUS CHANGES 2 0.0001
318 MASS 1 0.0001
319 WOUND 2 0.0001
320 CARPAL TUNNEL SYNDROME 1 0.0001
321 HYPONATRAEMIA 4 0.0001
322 SKIN REACTION 1 0.0001
323 BLINDNESS UNILATERAL 1 0.0001
324 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
325 SEPTIC SHOCK 3 0.0001
326 CARDIOMYOPATHY 1 0.0001
327 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
328 SKIN HAEMORRHAGE 1 0.0001
329 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
330 DEVICE FAILURE 1 0.0001
331 HIP ARTHROPLASTY 1 0.0001
332 HYPOKALAEMIA 3 0.0001
333 DEVICE RELATED INFECTION 1 0.0001
334 MUSCULOSKELETAL CHEST PAIN 1 0.0001
335 ANKLE FRACTURE 1 0.0001
336 RASH 28 0.0001
337 ACUTE MYELOID LEUKAEMIA 1 0.0001
338 SWOLLEN TONGUE 2 0.0001
339 PRODUCT USE COMPLAINT 1 0.0001
340 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
341 DYSPHAGIA 6 0.0001
342 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
343 OBESITY 1 0.0001
344 RHINORRHOEA 4 0.0001
345 BLOOD POTASSIUM INCREASED 1 0.0001
346 BLOOD CREATININE INCREASED 4 0.0001
347 STAPHYLOCOCCAL INFECTION 2 0.0001
348 BLOOD UREA INCREASED 1 0.0001
349 CELLULITIS 3 0.0001
350 FACE OEDEMA 1 0.0001
351 CANDIDA INFECTION 1 0.0001
352 HAEMATURIA 2 0.0001
353 PARANOIA 1 0.0001
354 OEDEMA PERIPHERAL 7 0.0001
355 ORTHOSTATIC HYPOTENSION 1 0.0001
356 LOCAL SWELLING 1 0.0001
357 SPEECH DISORDER 3 0.0001
358 EOSINOPHILIA 1 0.0001
359 INJURY 4 0.0001
360 HYPOXIA 2 0.0001
361 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
362 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
363 DRUG ERUPTION 1 0.0001
364 ISCHAEMIC STROKE 1 0.0001
365 GOUT 1 0.0001
366 LEUKOCYTOSIS 1 0.0001
367 OSTEOMYELITIS 1 0.0001
368 END STAGE RENAL DISEASE 1 0.0001
369 RESTLESSNESS 2 0.0001
370 THINKING ABNORMAL 1 0.0001
371 MIDDLE INSOMNIA 1 0.0001
372 EYE PAIN 3 0.0001
373 PHOTOPHOBIA 1 0.0001
374 DYSPNOEA EXERTIONAL 2 0.0001
375 BLOOD SODIUM DECREASED 1 0.0001
376 HYPOCALCAEMIA 1 0.0001
377 GASTRIC ULCER 1 0.0001
378 PULMONARY EMBOLISM 5 0.0001
379 LETHARGY 3 0.0001
380 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
381 HAEMORRHOIDS 1 0.0001
382 CHOKING 1 0.0001
383 SKIN FISSURES 1 0.0001
384 VISION BLURRED 7 0.0001
385 SINUS DISORDER 1 0.0001
386 CATARACT 3 0.0001
387 BLOOD PRESSURE ABNORMAL 1 0.0001
388 SPINAL FRACTURE 1 0.0000
389 PLEURAL EFFUSION 3 0.0000
390 RIB FRACTURE 1 0.0000
391 KNEE ARTHROPLASTY 1 0.0000
392 RENAL FAILURE ACUTE 2 0.0000
393 PLATELET COUNT DECREASED 5 0.0000
394 HYPOAESTHESIA 7 0.0000
395 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
396 VAGINAL HAEMORRHAGE 2 0.0000
397 ACUTE KIDNEY INJURY 7 0.0000
398 APPLICATION SITE PAIN 1 0.0000
399 FEBRILE NEUTROPENIA 3 0.0000
400 TACHYCARDIA 4 0.0000
401 DEHYDRATION 6 0.0000
402 TRANSAMINASES INCREASED 1 0.0000
403 THERAPY NON-RESPONDER 2 0.0000
404 HEART RATE IRREGULAR 1 0.0000
405 SKIN DISCOLOURATION 2 0.0000
406 SHOCK 1 0.0000
407 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
408 PALPITATIONS 5 0.0000
409 BLOOD PRESSURE FLUCTUATION 1 0.0000
410 LOCALISED INFECTION 1 0.0000
411 BRONCHITIS 3 0.0000
412 DRY EYE 2 0.0000
413 LEUKOPENIA 2 0.0000
414 HAEMATEMESIS 1 0.0000
415 INJECTION SITE SWELLING 3 0.0000
416 RASH GENERALISED 1 0.0000
417 DIPLOPIA 1 0.0000
418 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
419 MUSCULOSKELETAL PAIN 2 0.0000
420 BRADYCARDIA 2 0.0000
421 PYREXIA 13 0.0000
422 FEAR 1 0.0000
423 FREQUENT BOWEL MOVEMENTS 1 0.0000
424 THROAT TIGHTNESS 1 0.0000
425 NEUTROPENIA 5 0.0000
426 PNEUMONITIS 1 0.0000
427 GAIT DISTURBANCE 7 0.0000
428 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
429 PROCEDURAL PAIN 1 0.0000
430 ARTHROPATHY 2 0.0000
431 SEPSIS 4 0.0000
432 HAEMOPTYSIS 1 0.0000
433 DEMENTIA 1 0.0000
434 SKIN EXFOLIATION 3 0.0000
435 TARDIVE DYSKINESIA 1 0.0000
436 PAIN IN JAW 1 0.0000
437 MUSCULAR WEAKNESS 4 0.0000
438 INTENTIONAL DOSE OMISSION 1 0.0000
439 HYPOTENSION 7 0.0000
440 HERPES ZOSTER 2 0.0000
441 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
442 LIVER FUNCTION TEST ABNORMAL 1 0.0000
443 DYSSTASIA 1 0.0000
444 ASCITES 1 0.0000
445 URINARY INCONTINENCE 1 0.0000
446 WHEEZING 2 0.0000
447 BLOOD POTASSIUM DECREASED 1 0.0000
448 LACRIMATION INCREASED 1 0.0000
449 EPILEPSY 1 0.0000
450 LIMB DISCOMFORT 1 0.0000
451 FEMUR FRACTURE 1 0.0000
452 ANXIETY 9 0.0000
453 NEUROPATHY PERIPHERAL 3 0.0000
454 ANAEMIA 6 0.0000
455 ARTHRALGIA 13 0.0000
456 DEPRESSION 7 0.0000
457 OSTEONECROSIS 1 0.0000
458 EYE DISORDER 1 0.0000
459 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
460 VISUAL ACUITY REDUCED 1 0.0000
461 ABDOMINAL PAIN 7 0.0000
462 FUNGAL INFECTION 1 0.0000
463 SYNCOPE 3 0.0000
464 SKIN DISORDER 1 0.0000
465 URTICARIA 5 0.0000
466 EYE PRURITUS 1 0.0000
467 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
468 URINARY TRACT INFECTION 5 0.0000
469 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
470 ILLNESS 3 0.0000
471 DELIRIUM 1 0.0000
472 COUGH 8 0.0000
473 HYPERKALAEMIA 1 0.0000
474 HEART RATE DECREASED 1 0.0000
475 MOBILITY DECREASED 2 0.0000
476 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
477 PNEUMONIA 9 0.0000
478 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
479 CRYING 1 0.0000
480 CONSTIPATION 6 0.0000
481 PANIC ATTACK 1 0.0000
482 MUSCLE SPASMS 5 0.0000
483 AGITATION 2 0.0000
484 DYSURIA 1 0.0000
485 INJECTION SITE MASS 1 0.0000
486 HEPATIC FUNCTION ABNORMAL 1 0.0000
487 ASTHENIA 10 0.0000
488 COLITIS 1 0.0000
489 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
490 DIZZINESS 13 0.0000
491 PLASMA CELL MYELOMA 1 0.0000
492 CHILLS 3 0.0000
493 DISEASE PROGRESSION 3 0.0000
494 INJECTION SITE BRUISING 2 0.0000
495 CARDIAC FAILURE CONGESTIVE 2 0.0000
496 PSORIATIC ARTHROPATHY 1 0.0000
497 DEVICE BREAKAGE 1 0.0000
498 NEUTROPHIL COUNT DECREASED 1 0.0000
499 CARDIAC ARREST 2 0.0000
500 POLLAKIURIA 1 0.0000
501 CARDIO-RESPIRATORY ARREST 1 0.0000
502 ROAD TRAFFIC ACCIDENT 1 0.0000
503 ABDOMINAL DISCOMFORT 4 0.0000
504 OSTEOARTHRITIS 1 0.0000
505 HYPOACUSIS 1 0.0000
506 MENTAL DISORDER 1 0.0000
507 PAIN 14 0.0000
508 RENAL FAILURE 3 0.0000
509 MEMORY IMPAIRMENT 3 0.0000
510 SKIN IRRITATION 1 0.0000
511 NEPHROLITHIASIS 1 0.0000
512 NASOPHARYNGITIS 4 0.0000
513 CHEST PAIN 4 0.0000
514 HYPERSENSITIVITY 4 0.0000
515 DECREASED APPETITE 5 0.0000
516 BACK PAIN 5 0.0000
517 BREAST CANCER 2 0.0000
518 COGNITIVE DISORDER 1 0.0000
519 CARDIAC DISORDER 2 0.0000
520 FALL 7 0.0000
521 PRODUCTIVE COUGH 1 0.0000
522 MULTIPLE SCLEROSIS 1 0.0000
523 BLOOD GLUCOSE DECREASED 1 0.0000
524 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
525 HYPOGLYCAEMIA 1 0.0000
526 FATIGUE 16 0.0000
527 HEART RATE INCREASED 2 0.0000
528 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
529 FLUID RETENTION 1 0.0000
530 BLOOD PRESSURE INCREASED 3 0.0000
531 HOSPITALISATION 3 0.0000
532 PERIPHERAL SWELLING 3 0.0000
533 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
534 INFLAMMATION 1 0.0000
535 ABDOMINAL DISTENSION 2 0.0000
536 NERVOUSNESS 1 0.0000
537 ECZEMA 1 0.0000
538 DERMATITIS ATOPIC 1 0.0000
539 HYPERTENSION 4 0.0000
540 INSOMNIA 5 0.0000
541 OEDEMA 1 0.0000
542 TREMOR 3 0.0000
543 WEIGHT DECREASED 5 0.0000
544 NECK PAIN 1 0.0000
545 BLISTER 1 0.0000
546 NAUSEA 14 0.0000
547 DYSPNOEA 10 0.0000
548 FLATULENCE 1 0.0000
549 EYE IRRITATION 1 0.0000
550 DIARRHOEA 11 0.0000
551 NASAL CONGESTION 1 0.0000
552 PAIN IN EXTREMITY 5 0.0000
553 IRRITABILITY 1 0.0000
554 THERAPEUTIC RESPONSE DECREASED 1 0.0000
555 STOMATITIS 1 0.0000
556 VERTIGO 1 0.0000
557 FEELING HOT 1 0.0000
558 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
559 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
560 LOSS OF CONSCIOUSNESS 2 0.0000
561 SWELLING FACE 1 0.0000
562 INFUSION RELATED REACTION 1 0.0000
563 BLOOD PRESSURE DECREASED 1 0.0000
564 DRY SKIN 2 0.0000
565 INJECTION SITE PRURITUS 1 0.0000
566 INJECTION SITE REACTION 1 0.0000
567 HEADACHE 9 0.0000
568 SLEEP DISORDER 1 0.0000
569 SKIN BURNING SENSATION 1 0.0000
570 INFECTION 2 0.0000
571 RESPIRATORY FAILURE 1 0.0000
572 OFF LABEL USE 12 0.0000
573 DYSGEUSIA 1 0.0000
574 WEIGHT INCREASED 3 0.0000
575 UNEVALUABLE EVENT 1 0.0000
576 CHRONIC KIDNEY DISEASE 1 0.0000
577 CONDITION AGGRAVATED 4 0.0000
578 INCORRECT DOSE ADMINISTERED 3 0.0000
579 DIABETES MELLITUS 1 0.0000
580 VOMITING 6 0.0000
581 ARTHRITIS 1 0.0000
582 PARAESTHESIA 2 0.0000
583 CARDIAC FAILURE 1 0.0000
584 THROMBOSIS 1 0.0000
585 CONFUSIONAL STATE 2 0.0000
586 RENAL IMPAIRMENT 1 0.0000
587 MYALGIA 2 0.0000
588 BALANCE DISORDER 1 0.0000
589 PRODUCT STORAGE ERROR 1 0.0000
590 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
591 MUSCULOSKELETAL STIFFNESS 1 0.0000
592 COVID-19 2 0.0000
593 GASTROINTESTINAL DISORDER 1 0.0000
594 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
595 ADVERSE EVENT 1 0.0000
596 OROPHARYNGEAL PAIN 1 0.0000
597 CONTUSION 1 0.0000
598 ATRIAL FIBRILLATION 1 0.0000
599 SOMNOLENCE 2 0.0000
600 CHEST DISCOMFORT 1 0.0000
601 SINUSITIS 1 0.0000
602 MALAISE 4 0.0000
603 INFLUENZA 1 0.0000
604 THROMBOCYTOPENIA 1 0.0000
605 ASTHMA 1 0.0000
606 RHEUMATOID ARTHRITIS 1 0.0000
607 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
608 FEELING ABNORMAL 2 0.0000
609 EMOTIONAL DISTRESS 1 0.0000
610 DEATH 7 0.0000
611 HYPERHIDROSIS 1 0.0000
612 PSORIASIS 1 0.0000
613 DRUG INEFFECTIVE 9 0.0000
614 DRUG DOSE OMISSION 1 0.0000
615 TOXICITY TO VARIOUS AGENTS 1 0.0000
616 CEREBROVASCULAR ACCIDENT 1 0.0000
617 PRODUCT USE ISSUE 1 0.0000
618 BLOOD GLUCOSE INCREASED 1 0.0000
619 ALOPECIA 1 0.0000
620 ERYTHEMA 1 0.0000
621 ABDOMINAL PAIN UPPER 1 0.0000
622 PRODUCT DOSE OMISSION ISSUE 1 0.0000